Walnut Level Capital LLC Raises Stock Position in The Chemours Company (NYSE:CC)

Walnut Level Capital LLC lifted its holdings in The Chemours Company (NYSE:CC - Free Report) by 60.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 80,000 shares of the specialty chemicals company's stock after buying an additional 30,000 shares during the quarter. Chemours makes up about 0.5% of Walnut Level Capital LLC's portfolio, making the stock its 28th biggest position. Walnut Level Capital LLC owned 0.05% of Chemours worth $1,352,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently modified their holdings of CC. Corient Private Wealth LLC raised its stake in shares of Chemours by 4.7% during the fourth quarter. Corient Private Wealth LLC now owns 13,428 shares of the specialty chemicals company's stock valued at $227,000 after acquiring an additional 604 shares in the last quarter. GAMMA Investing LLC raised its position in Chemours by 99.7% during the 4th quarter. GAMMA Investing LLC now owns 1,532 shares of the specialty chemicals company's stock valued at $26,000 after purchasing an additional 765 shares in the last quarter. HUB Investment Partners LLC lifted its holdings in shares of Chemours by 1.4% in the 4th quarter. HUB Investment Partners LLC now owns 58,250 shares of the specialty chemicals company's stock worth $984,000 after buying an additional 821 shares during the period. ARGA Investment Management LP grew its position in shares of Chemours by 0.7% during the 4th quarter. ARGA Investment Management LP now owns 148,614 shares of the specialty chemicals company's stock worth $2,512,000 after buying an additional 1,032 shares in the last quarter. Finally, Heritage Investors Management Corp increased its stake in shares of Chemours by 1.1% during the fourth quarter. Heritage Investors Management Corp now owns 105,322 shares of the specialty chemicals company's stock valued at $1,780,000 after buying an additional 1,174 shares during the period. 76.26% of the stock is owned by institutional investors.

Remove Ads

Analyst Ratings Changes

A number of research firms recently weighed in on CC. Barclays lowered their price objective on shares of Chemours from $23.00 to $19.00 and set an "equal weight" rating for the company in a research note on Monday, February 24th. Morgan Stanley dropped their price objective on shares of Chemours from $25.00 to $22.00 and set an "equal weight" rating on the stock in a research note on Monday, January 13th. Royal Bank of Canada restated an "outperform" rating and set a $25.00 target price on shares of Chemours in a report on Thursday, December 12th. Truist Financial began coverage on Chemours in a research report on Tuesday, January 28th. They issued a "buy" rating and a $27.00 price target for the company. Finally, BMO Capital Markets dropped their price objective on Chemours from $34.00 to $27.00 and set an "outperform" rating on the stock in a research report on Wednesday, February 19th. Five research analysts have rated the stock with a hold rating and four have issued a buy rating to the company's stock. Based on data from MarketBeat.com, Chemours currently has an average rating of "Hold" and a consensus target price of $23.11.

Chemours Stock Down 2.0 %

Shares of CC stock traded down $0.29 during trading hours on Tuesday, reaching $14.16. 1,792,271 shares of the company's stock were exchanged, compared to its average volume of 1,673,162. The Chemours Company has a 1 year low of $13.09 and a 1 year high of $29.21. The company has a current ratio of 1.68, a quick ratio of 0.92 and a debt-to-equity ratio of 6.70. The stock has a market cap of $2.12 billion, a PE ratio of 24.84 and a beta of 2.00. The stock's fifty day moving average price is $16.72 and its two-hundred day moving average price is $18.27.

Chemours (NYSE:CC - Get Free Report) last issued its quarterly earnings results on Tuesday, February 18th. The specialty chemicals company reported $0.11 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.10 by $0.01. The business had revenue of $1.36 billion for the quarter, compared to analyst estimates of $1.37 billion. Chemours had a net margin of 1.51% and a return on equity of 26.54%. Research analysts predict that The Chemours Company will post 2.03 EPS for the current year.

Chemours Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, March 14th. Stockholders of record on Friday, February 28th were paid a $0.25 dividend. This represents a $1.00 annualized dividend and a dividend yield of 7.06%. The ex-dividend date of this dividend was Friday, February 28th. Chemours's payout ratio is 175.44%.

Chemours Company Profile

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.